.Pharmacolibrary.Drugs.R_RespiratorySystem.R05D_CoughSuppressantsExclCombinationsWithExpectorant.R05DB27_Levodropropizine.Levodropropizine .Pharmacolibrary.Drugs.R_RespiratorySystem.R05D_CoughSuppressantsExclCombinationsWithExpectorant.R05DB27_Levodropropizine.Levodropropizine| name: | Levodropropizine |
| ATC code: | R05DB27 | route: | oral |
| n-compartments | 1 |
Levodropropizine is a non-opioid antitussive drug used for the symptomatic treatment of cough. It acts as a peripheral cough suppressant and is available in many countries over-the-counter or as prescription medication, but is not approved by the US FDA.
Healthy adult volunteers, after oral administration of levodropropizine. Pharmacokinetic parameters estimated from population PK study.
Jang, JW, et al., & Lee, KT (2013). Relative bioavailability of levodropropizine 60 mg capsule and syrup formulations in healthy male Korean volunteers: a singledose, randomized-sequence, open-label, two-way crossover study. International journal of clinical pharmacology and therapeutics 51(2) 152–160. DOI:10.5414/cp201730 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23351597